dc.contributor.author |
Jagtap, Rohidas |
|
dc.contributor.author |
Thorat, S.H. |
|
dc.contributor.author |
Gonnade, R.G. |
|
dc.contributor.author |
Khan, A.K. |
|
dc.contributor.author |
Pardeshi, Satish |
|
dc.date.accessioned |
2020-03-05T09:23:57Z |
|
dc.date.available |
2020-03-05T09:23:57Z |
|
dc.date.issued |
2017-12-05 |
|
dc.identifier.uri |
https://pubs.rsc.org/en/content/articlelanding/2018/nj/c7nj02961f#!divAbstract |
|
dc.identifier.uri |
http://hdl.handle.net/123456789/245 |
|
dc.description.abstract |
Diastereomeric ‘2RS,4R’-2-arylthiazolidine-4-carboxylic acids (ATCAs) were synthesized and their resolution to chiraly pure N-BOC derivatives was attempted by column chromatography. The absolute stereochemistry of the resolved compounds was ascertained by X-ray single crystal structures. Further application of the synthesized compounds was studied for their in vitro anti-breast cancer activity against MCF7 cell line using DOX as a standard by MTT assay method. Cell morphology analysis was carried out by fluorescence microscopy. The compounds containing ‘2S’ absolute configuration in thiazolidine ring and presence of 2-NO2, 2,6-Cl groups on ‘2R’-aryl substituent showed significant anti-breast cancer activity where some of the compounds were found to be more active than DOX in terms of induced apoptosis mode of MCF7 cell death. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Royal Society of Chemistry's New Journal of Chemistry Issue 2, 2018 |
en_US |
dc.subject |
CHEMISTRY |
en_US |
dc.subject |
X-RAY CRYSTALS |
en_US |
dc.subject |
ANTI BREAST CANCER PROPERTY |
en_US |
dc.subject |
CARBOXYLIC ACIDS |
en_US |
dc.title |
X-ray crystal structures and anti-breast cancer property of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acids† |
en_US |
dc.type |
Research Paper |
en_US |